+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the radiotherapy boost on local control in ductal carcinoma in situ



Role of the radiotherapy boost on local control in ductal carcinoma in situ



International Journal of Surgical Oncology 2012: 748196



Ductal carcinoma in situ of the breast is associated with low mortality rates, but local relapse is a matter of concern in this disease. Risk factors for local relapse include young age, close or positive margins, and tumor necrosis. Whole breast irradiation following breast-conserving surgery for ductal carcinoma in situ significantly reduces the risk of local relapse as compared to breast-conserving surgery alone. Studies point to similar outcomes between breast-conserving surgery plus radiotherapy and mastectomy, in the absence of extensive disease. A complementary boost to the surgical bed improves outcomes for patients with invasive breast cancer. However, the effect of this strategy has never been prospectively reported for ductal carcinoma in situ. Two randomized controlled trials assessing this issue are ongoing. This paper represents an update on available literature about radiotherapy for DCIS with a special focus on the role of a radiotherapy boost to the tumor bed.

(PDF emailed within 0-6 h: $19.90)

Accession: 055614421

Download citation: RISBibTeXText

PMID: 22577533

DOI: 10.1155/2012/748196


Related references

Ductal carcinoma in situ--the influence of the radiotherapy boost on local control. International Journal of Radiation Oncology, Biology, Physics 82(2): E153-E158, 2012

Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients. European Journal of Surgical Oncology 39(6): 613-618, 2013

Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ. Cancer 117(1): 54-62, 2011

Is radiotherapy boost needed in young patients with ductal carcinoma-in-situ?. Lancet. Oncology 7(8): 615-617, 2006

Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ. RadioTherapy and Oncology 95(3): 317-320, 2010

Ductal carcinoma in situ: role of the boost. Cancer Radiotherapie 12(6-7): 571-576, 2008

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet. Oncology 7(8): 652-656, 2006

Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences. Cancer Radiotherapie 20(4): 292-298, 2017

Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04). Breast Cancer Research and Treatment 146(2): 341-345, 2015

Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 71(2): 393-400, 2008

Ductal carcinoma in situ treated by wide local excision without radiotherapy. Breast Cancer Research & Treatment 41(3): 238, 1996

Is it safe to omit radiotherapy following wide local excision for ductal carcinoma in situ?. Surgeon 7(3): 146-150, 2009

Ductal carcinoma in situ Role of radiotherapy. Ioannidou-Mouzaka, L , Agnantis, N J , Karydas, I International Congress Series; Senology : 231-234, 1992

Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age. Annals of Surgical Oncology 13(7): 990-998, 2006

10-year follow-up showed benefit of adding radiotherapy to local excision for ductal carcinoma in situ. Acp Journal Club 146(1): 3, 2007